IKT Competitors & Alternatives
Compare Inhibikase Therapeutics Inc with similar stocks in the same industry
Biotechnology
IKT
Main Stock$1.52
-0.65%
Tradestie Score
48
Market Cap
$119.97M
Revenue Growth
-100.0%
Analyst Upside
+294.7%
Supply-Chain & Ecosystem Map (Customers, Suppliers & Direct Competitors)
Bottleneck Score: 2/10
Drug Discovery Biotech
Drug Design
Top Competitors
222 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
VOR
Vor Biopharma Inc. Common Stock
|
$19.42
+0.52%
|
$269.08M | 0.1 | 42 | Compare |
|
VYGR
Voyager Therapeutics, Inc. Common Stock
|
$1.73
+1.76%
|
$259.59M | - | 42 | Compare |
|
VTYX
Ventyx Biosciences, Inc. Common Stock
|
$14.00
+0.14%
|
$256.71M | - | 51 | Compare |
|
SLN
Silence Therapeutics Plc American Depository Share
|
$19.83
+0.15%
|
$240.89M | - | 42 | Compare |
|
OABI
OmniAb, Inc. Common Stock
|
$4.91
-0.81%
|
$231.77M | - | 48 | Compare |
|
SGMT
Sagimet Biosciences Inc. Series A Common Stock
|
$10.22
-6.50%
|
$227.00M | - | 47 | Compare |
|
SLS
SELLAS Life Sciences Group, Inc. Common Stock
|
$7.86
-2.12%
|
$211.22M | - | 63 | Compare |
|
ACRS
Aclaris Therapeutics, Inc.
|
$3.92
-2.00%
|
$202.58M | - | 38 | Compare |
|
CBIO
Crescent Biopharma, Inc. Common Stock
|
$14.15
-1.53%
|
$199.71M | - | 37 | Compare |
|
FBRX
Forte Biosciences, Inc. Common Stock
|
$76.99
+0.03%
|
$180.53M | - | 54 | Compare |
More IKT Analysis
Data updated: Nov 15, 2026 | Industry: Biotechnology (SIC 2836)
222 stocks in this industry